Self-assembled PEGylated albumin nanoparticles (SPAN) as a platform for cancer chemotherapy and imaging. (1st January 2018)
- Record Type:
- Journal Article
- Title:
- Self-assembled PEGylated albumin nanoparticles (SPAN) as a platform for cancer chemotherapy and imaging. (1st January 2018)
- Main Title:
- Self-assembled PEGylated albumin nanoparticles (SPAN) as a platform for cancer chemotherapy and imaging
- Authors:
- Lee, Jung Eun
Kim, Myung Goo
Jang, Yeon Lim
Lee, Min Sang
Kim, Nak Won
Yin, Yue
Lee, Jong Han
Lim, Su Yeon
Park, Ji Won
Kim, Jaeyun
Lee, Doo Sung
Kim, Sun Hwa
Jeong, Ji Hoon - Abstract:
- Abstract: Paclitaxel (PTX) is used as a major antitumor agent for the treatment of recurrent and metastatic breast cancer. For the clinical application of PTX, it needs to be dissolved in an oil/detergent-based solvent due to its poor solubility in an aqueous medium. However, the formulation often causes undesirable complications including hypersensitivity reactions and limited tumor distribution, resulting in a lower dose-dependent antitumor effect. Herein, we introduce a facile and oil-free method to prepare albumin-based PTX nanoparticles for efficient systemic cancer therapy using a conjugate of human serum albumin (HSA) and poly(ethyleneglycol) (PEG). PTX were efficiently incorporated in the self-assembled HSA-PEG nanoparticles (HSA-PEG/PTX) using a simple film casting and re-hydration procedure without additional processes such as application of high pressure/shear or chemical crosslinking. The spherical HSA-PEG nanoparticle with a hydrodynamic diameter of ca. 280 nm mediates efficient cellular delivery, leading to comparable or even higher cytotoxicity in various breast cancer cells than that of the commercially available Abraxane ® . When systemically administered in a mouse xenograft model for human breast cancer, the HSA-PEG-based nanoparticle formulation exhibited an extended systemic circulation for more than 96 h and enhanced intratumoral accumulation, resulting in a remarkable anticancer effect and prolonged survival of the animals.
- Is Part Of:
- Drug delivery. Volume 25:Number 1(2018)
- Journal:
- Drug delivery
- Issue:
- Volume 25:Number 1(2018)
- Issue Display:
- Volume 25, Issue 1 (2018)
- Year:
- 2018
- Volume:
- 25
- Issue:
- 1
- Issue Sort Value:
- 2018-0025-0001-0000
- Page Start:
- 1570
- Page End:
- 1578
- Publication Date:
- 2018-01-01
- Subjects:
- Drug dissolution -- oil-free formulation -- human serum albumin -- self-assembled nanoparticle -- systemic cancer therapy
Drug delivery systems -- Periodicals
Drug targeting -- Periodicals
615.05 - Journal URLs:
- http://informahealthcare.com/loi/drd ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/10717544.2018.1489430 ↗
- Languages:
- English
- ISSNs:
- 1071-7544
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.104600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18555.xml